Find Academic Supervisors

Eduardo Rocha is a Professor and Head of the Microbial Evolutionary Genomics laboratory at the Institut Pasteur, within the Department of Genomes and Genetics. His research integrates bioinformatics, molecular evolution, and genomics to understand bacterial genome organization and dynamics, particularly focusing on mobile genetic elements and their role in adaptation and antibiotic resistance. His research interests include microbial evolutionary genomics, genome organization, horizontal gene transfer, mobile genetic elements (plasmids, phages, integrons), bacterial pathogen evolution, and computational biology. His work lies at the intersection of molecular evolution, population genetics, and molecular epidemiology, with strong translational implications for understanding antimicrobial resistance and infectious disease emergence. The recent publications highlight a consistent focus on mobile genetic elements, genome plasticity, and bacterial adaptation. Key themes include the role of integrons and CRISPR-Cas systems in bacterial immunity, plasmid-mediated spread of antibiotic resistance, phage-plasmid interactions, and the development of bioinformatics tools for microbial genomics. These works frequently appear in high-impact journals such as Science , Nature Microbiology , and PLoS Biology , reflecting significant contributions to the field. Eduardo Rocha leads multiple funded research projects, including ERC-2011-StG EVOMOBILOME, ANR Magisbac, and ANR SHAPE. He has developed and maintains several widely used bioinformatics software tools: IntegronFinder, MacSyFinder, PanACoTA, SatelliteFinder, CapsuleFinder, TXSScan, and others. He mentors a large team of PhD students, postdoctoral researchers, and engineers, and has supervised numerous former students who now hold independent research positions worldwide. Eduardo Rocha has received research funding from major agencies including the European Research Council (ERC) and the French National Research Agency (ANR). His work is central to the LabEx IBEID and the INCEPTION convergence program, where he serves on the steering committee, promoting interdisciplinary research in infectious disease emergence. His laboratory, part of the Genomes and Genetics department, actively contributes to microbial evolutionary genomics through both methodological development and biological discovery. The team participates in networks such as Phages.fr, GDR BIM, and GDR AIEM, reinforcing its collaborative and integrative approach.

• Microbial Evolutionary Genomics
• Genome Organization
• Mobile Genetic Elements
• +13 more

Olivier Lortholary is Professor of Medicine at Paris Descartes University and holds multiple significant positions in the field of medical mycology and infectious diseases. He serves as Deputy Director of the French National Reference Center for Invasive Mycoses and Antifungals, and is Head of the Necker-Pasteur Center for Infectious Diseases and Tropical Medicine at Necker Hospital in Paris. His work is closely associated with the Institut Pasteur in Paris, France, where he is actively involved in research and teaching initiatives. Dr. Lortholary's educational background includes an M.D. from the Paris 6 School of Medicine and a Ph.D. from Paris 7 University. His extensive academic career has positioned him as a leading expert in medical mycology, with particular focus on fungal infections in immunocompromised patients. His research primarily centers on translational aspects of medical mycology, with special emphasis on Cryptococcus neoformans and cryptococcal meningitis, which represents the leading opportunistic fungal infection in advanced HIV-infected patients. He also investigates new immune deficiencies that predispose individuals to invasive fungal infections, develops diagnostic and therapeutic innovations for these conditions, and conducts clinical and microbiological studies of central nervous system infections and emerging infectious diseases. Dr. Lortholary has made substantial contributions to the field, with over 590 published papers, including more than 12 invited contributions to prestigious journals such as Clinical Infectious Diseases and Lancet Infectious Diseases. His research spans epidemiology of fungal infections, antifungal susceptibility testing, and clinical management approaches across various patient populations. He plays a significant role in shaping clinical guidelines as a member of various international expert panels, including the Infectious Diseases Society of America (for cryptococcosis management), the American Society of Transplantation (for donor-derived fungal infections), and ESCMID (for Candida and other fungal infections). Additionally, he serves as the French representative on the EUCAST Antifungal Susceptibility Testing Committee. As an educator, Dr. Lortholary co-directs the Medical Mycology course at the Pasteur Institute and has developed a MOOC (Massive Open Online Course) on Medical Mycology available through FUN-MOOC, reaching a global audience of healthcare professionals and researchers.

• Medical Mycology
• Infectious Diseases
• Translational Research
• +7 more

Hugues Aschard is a Principal Investigator and Structure Manager at the Pasteur Institute in Paris, where he leads research in statistical genetics, microbiome analysis, and computational genomics. He is the principal investigator of the MicMat project, the EpiGenCOV Consortium, and several bioinformatics software initiatives including JASS, RAISS, and MGMM. Research Interests: Statistical and computational methods in genetics Genome-wide association studies (GWAS) Gene-environment interactions Microbiome and host genetics in inflammatory bowel disease Genetic epidemiology of infectious diseases like COVID-19 Development of open-source tools for multi-trait and summary-statistic analysis Recent Research Trends: His recent publications and projects emphasize integrative genetic modeling, multi-trait analysis across diverse populations, and the development of novel computational methods to handle missing data and improve SNP discovery. His work bridges statistical innovation with biological and clinical applications in complex diseases. Scientific Contributions: Development of JASS, RAISS, and MGMM software tools Leadership in large-scale consortia like EpiGenCOV Advancing methods for cross-ancestry genetic studies Advising and Collaboration: He supervises multiple PhD students and postdoctoral fellows, including Christophe Boetto, Antoine Auvergne, and Lucas Chataigner. He collaborates with major institutions such as APHP and CNRGH. His team includes research engineers and administrative staff, indicating an active and well-supported research group. Laboratories and Teams: He is a key member of the Biomaterials and Microfluidics team at the Pasteur Institute, where he contributes to interdisciplinary research involving Bayesian decision processes and genetic modeling.

• Statistical Genetics
• Genome-Wide Association Studies (GWAS)
• Microbiome Research
• +7 more

Julia Chamot-Rooke is a Principal Investigator and Researcher at the Institut Pasteur in Paris, France, affiliated with the Department of Structural Biology and Chemistry and the Mass Spectrometry for Biology unit (UTechS MSBio), a joint CNRS service and research unit (USR2000). She leads multiple projects in advanced proteomics and is the PI for the Institut Pasteur in the European Proteomics Infrastructure Consortium providing access (EPIC-XS). Her research focuses on developing innovative methods in top-down proteomics , cross-linking mass spectrometry , and structural proteomics to study intact proteins, post-translational modifications, and protein complexes. Her work has applications in microbiology, infectious diseases, and host-pathogen interactions. She has developed the ProteoCombiner software to integrate proteomics data for improved proteoform characterization. The recent publications reflect a strong emphasis on structural and functional proteomics , particularly in microbial systems and immune interactions. Trends include the use of advanced mass spectrometry techniques (HDX-MS, cross-linking MS, top-down MS) to investigate protein structure, dynamics, and interactions in pathogens and host systems. There is also a growing focus on software and tool development to enhance data analysis and reproducibility in proteomics. Principal Investigator, EPIC-XS at Institut Pasteur Coordinator, Joint Research Activity on Future and Emerging Proteomics Technologies Lead Developer, ProteoCombiner software She supervises PhD students and research engineers and collaborates widely on projects involving bacterial pathogenesis, immune evasion, and structural biology. Her lab is equipped with state-of-the-art Orbitrap mass spectrometers and participates in transnational access programs, providing cutting-edge proteomics services to the European research community.

• Proteomics
• Structural Biology
• Mass Spectrometry
• +7 more

Wouter Bos is a Research Director at CNRS working at the Laboratory of Fluid Mechanics and Acoustics (LMFA) at École Centrale de Lyon, France. He leads research within the Turbulence & Instabilities team, focusing on fundamental aspects of fluid dynamics with applications spanning from plasma physics to epidemiology. His academic journey reflects a deep engagement with theoretical and computational fluid mechanics, particularly in turbulence phenomena. Dr. Bos's research interests center on fluid dynamics, with particular emphasis on turbulence in various contexts including two-dimensional flows, magnetohydrodynamics, plasma physics, and statistical mechanics of fluids. His work explores fundamental questions about energy transfer, coherent structures, and statistical properties of turbulent flows. He has made significant contributions to understanding turbulence without vortex stretching, two-dimensional turbulence, and the application of fluid dynamics principles to epidemiological modeling. Analysis of his recent publications reveals a strong focus on theoretical and computational approaches to turbulence. His work spans from fundamental questions about equilibrium states in two-dimensional turbulence to practical applications in plasma confinement and epidemic modeling. The publications demonstrate consistent innovation in turbulence theory, with particular attention to statistical mechanics approaches, spectral analysis, and the development of reduced-order models for complex fluid phenomena. His research shows growing interdisciplinary connections, especially between fluid dynamics and epidemiology as evidenced by his work on modeling the spread of infectious diseases. Dr. Bos actively supervises doctoral students and postdoctoral researchers, with recent students including Tong Wu, Ryo Araki, Smiron Varghese, Wesley Agoua, and Bruce (Xi Yuan) Yin. He participates in collaborative research projects such as the ANR CM2E project (2021-2025) on Characteristic Mapping Method for the Euler Equations, working with researchers from Aix-Marseille University and McGill University. His laboratory work involves both theoretical analysis and computational simulations, with applications ranging from fundamental fluid mechanics to practical problems in energy research (particularly related to ITER and fusion plasma physics) and public health. The interdisciplinary nature of his research demonstrates the broad applicability of fluid dynamics principles across seemingly disparate scientific domains.

• Fluid Dynamics
• Turbulence
• Magnetohydrodynamics
• +3 more

Stanislas Lyonnet is Professor of Genetics at the Paris Descartes Faculty of Medicine and a geneticist at the Necker-Enfants Malades University Hospital in Paris. Since 2016, he has served as Director of the Institute for Genetic Diseases (Imagine), a position that builds on his extensive leadership in genetic research and clinical practice. His career spans several key roles including directing the 'Genetics and Embryology of Malformations' laboratory from 1992 until 2016 and coordinating the Necker site of the National Reference Center for Rare Diseases. Lyonnet's research focuses on the genetic basis and molecular pathophysiology of congenital malformations, with nearly 400 international publications spanning from 1985 to 2019. His work has significantly contributed to understanding rare genetic disorders, developmental anomalies, and malformation syndromes. Recent publications demonstrate his ongoing contributions to next-generation phenotyping techniques, genotype-phenotype correlations, and the molecular mechanisms underlying various genetic conditions including Coffin-Siris syndrome, ciliopathies, and neurodevelopmental disorders. Inserm Research Prize (2009) Collery Prize from the French Academy of Medicine President of the European Society of Human Genetics (2013) Throughout his career, Lyonnet has been deeply committed to knowledge transfer, having directed the European Master's in Genetics at the University of Paris from 2004 to 2017 and authored educational materials including 'Les 100 mots de la génétique.' He currently chairs the scientific council of the École Normale Supérieure (Ulm) and continues to lead research initiatives at Imagine, focusing on advancing the understanding and treatment of genetic diseases through interdisciplinary collaboration and cutting-edge genomic approaches.

• Genetics
• Congenital Malformations
• Rare Diseases
• +3 more

Félix Rey is a leading Research Professor at the Structural Virology Unit within the Virology Department of the Institut Pasteur in Paris, France. He spearheads multidisciplinary studies on viral and cellular membrane fusion mechanisms, with a focus on emerging viruses such as Chikungunya , Dengue , and SARS-CoV-2 . His research explores: Structural biology of virus envelope glycoproteins (e.g., Chikungunya p62-E1, Hepatitis C E2, Foamy virus Env). Molecular interactions in viral entry and neutralization. Cell-cell fusion mechanisms in fertilization and development. Recent publications highlight structural insights into: 2025 : SARS-CoV-2 spike protein conformational dynamics and ACE2 receptor interactions. 2024 : Foamy virus fusion protein evolution, TMPRSS2's role in HKU1 coronavirus entry. 2023 : Yellow fever virus maturation, pan-hantavirus neutralization antibodies. He collaborates with teams across France , Southeast Asia , and West/Central Africa through the Pasteur International Center for Research on Emerging Infectious Diseases . Current advisees include Paul Courrieu and Marius Allombert (Master's students).

• Structural Biology
• Virology
• Molecular Biology
• +3 more

Monica Rolando is a researcher at the Institut Pasteur in Paris, France, specializing in the study of intracellular bacterial pathogens, particularly Legionella pneumophila , the causative agent of Legionnaires' disease. She is affiliated with the Biology of Intracellular Bacteria department and teaches in the Pasteur Microbiology Course, sharing her expertise in bacterial pathogenesis and host-pathogen interactions. Dr. Rolando obtained her PhD in Cellular and Molecular Biology from the University of Nice-Sophia Antipolis, where she studied bacterial toxins targeting the host endothelium. In 2009, she joined the laboratory of Carmen Buchrieser at the Institut Pasteur for postdoctoral training, shifting her focus to non-toxin-mediated aspects of host-pathogen interactions. Her research primarily focuses on how bacterial pathogens manipulate host cellular processes, with particular emphasis on epigenetic regulation. Dr. Rolando investigates how Legionella pneumophila employs bacterial effectors that target the host cell nucleus to modify epigenetic marks, thereby subverting host cell functions to facilitate bacterial replication. Her work explores the fascinating co-evolution between L. pneumophila and its eukaryotic hosts, which has led to the acquisition of proteins through horizontal gene transfer that allow the bacterium to mimic eukaryotic functions. Analysis of Dr. Rolando's recent publications reveals a strong focus on patho-epigenetics - the manipulation of host epigenetic machinery by bacterial pathogens. Her research spans molecular mechanisms of bacterial effectors, particularly histone-modifying enzymes like methyltransferases, and their role in subverting host defenses. A significant portion of her work examines how Legionella and related pathogens target chromatin structure and nuclear processes to promote intracellular survival and replication. Dr. Rolando has contributed to numerous collaborative research projects at the Institut Pasteur, working with various research teams investigating bacterial pathogenesis. Her work bridges molecular microbiology, cell biology, and epigenetics, providing novel insights into host-pathogen interactions at the molecular level. Her laboratory focuses on identifying and characterizing bacterial effectors that target host nuclear processes, with particular attention to how these effectors modify epigenetic marks to benefit bacterial replication. This research has important implications for understanding bacterial pathogenesis and potentially developing novel anti-infective strategies targeting pathogen epigenetic manipulation.

• Epigenetics
• Host-pathogen interactions
• Microbiology
• +4 more

V Stalin Raj serves as an Associate Professor in the School of Biology at the Indian Institute of Science Education and Research (IISER) Thiruvananthapuram, where he leads research on coronavirus virology and host-pathogen interactions. Previously, he worked as a Scientist at Erasmus Medical Center in Rotterdam, Netherlands (2010-2017) and completed postdoctoral training at the University of Liege, Belgium. Dr. Raj earned his PhD in Biotechnology from the University of Madras in 2007, with thesis research on White Spot Syndrome Virus and Monodon Baculovirus affecting farmed Penaeus monodon. His academic journey includes a BSc in Microbiology (1999) from the University of Madras and an MSc in Biotechnology (2001) from Madurai Kamaraj University. His primary research focuses on coronavirus entry mechanisms, virus-host interactions, and vaccine development. Dr. Raj is particularly known for his work identifying dipeptidyl peptidase 4 (DPP4) as the functional receptor for MERS-CoV, published in Nature (2013). His laboratory investigates how coronaviruses like MERS-CoV and SARS-CoV-2 enter host cells, with emphasis on developing broad-spectrum antivirals and thermostable vaccines suitable for resource-limited settings. Current projects explore natural compounds like EGCG from green tea as potential inhibitors of viral entry across multiple coronavirus strains. Analysis of his recent publication record reveals a strong focus on coronavirus spike protein interactions, neutralizing antibody development, and innovative vaccine platforms. His work spans fundamental virology to translational applications, with increasing emphasis on addressing challenges posed by SARS-CoV-2 variants and the need for broadly reactive coronavirus countermeasures. Scientific Recognition Co-author on multiple high-impact papers in Nature , Science , The Lancet Infectious Diseases , and PNAS Key contributor to identifying DPP4 as the MERS-CoV receptor, a fundamental discovery in coronavirus research Recipient of postdoctoral fellowships at University of Liege and research opportunities at prestigious institutions including Erasmus MC Dr. Raj serves as a journal referee for Emerging Infectious Disease (CDC), Eurosurveillance (ECDC), Journal of Virological Methods, and other prominent virology publications. His research program at IISER Thiruvananthapuram focuses on developing thermostable vaccine platforms and investigating mechanisms of viral entry inhibition, with particular attention to making coronavirus countermeasures accessible in resource-limited settings worldwide.

• Coronaviruses
• Vaccine Development
• Virus Discovery
• +3 more

Clément De Chaisemartin is a Professor of Economics at Sciences Po since 2021, affiliated with the National Bureau of Economic Research (NBER) and J-PAL. His work focuses on econometric methods for policy evaluation and the economics of education. He holds a PhD from EHESS and Paris School of Economics (PSE), and previously taught at the University of Warwick and University of California, Santa Barbara (UCSB). Key research includes the evaluation of educational interventions, such as boarding schools for disadvantaged students, and methodological contributions to difference-in-differences (DID) estimators. Notable awards include the AFSE-Malinvaud Prize (2019) for his work on fuzzy DID. He co-authored influential papers in American Economic Review , Econometrica , and Review of Economic Studies , and developed Stata/R packages like did_multiplegt and twowayfeweights . Current projects include a textbook on DID methods and collaborations on multi-site randomized trials. Education: PhD in Economics (2013), École des Hautes Études en Sciences Sociales (EHESS) and Paris School of Economics (PSE). Research Interests: Causal inference, policy evaluation, educational disparities, and econometric methods. Grants & Projects: Research funded by French health/education authorities, including evaluations of early childhood programs like Parler Bambin. Teams: Maintains a research team and GitHub page for open-source econometric tools. His op-eds advocate for broader use of impact evaluation in public policy, critiquing private-sector dominance in applying such tools.

• Econometrics
• Economics of Education
• Policy Evaluation
• +3 more

Lucy Glover is a Researcher and Group Leader of the Trypanosome Molecular Biology laboratory at the Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France. She joined the institute in March 2016 as a G5 group leader, focusing on the molecular mechanisms of antigenic variation and DNA repair in Trypanosoma brucei , the causative agent of Human African Trypanosomiasis. Her research integrates molecular, biochemical, and high-throughput approaches to study DNA recombination and immune evasion. Institut Pasteur, Paris (2016–Present) PhD, London School of Hygiene and Tropical Medicine Her research interests center on antigenic variation , DNA repair , and homologous recombination in trypanosomes. She investigates how DNA double-strand breaks influence variant surface glycoprotein (VSG) switching, a critical process for parasite survival in the host. Her lab uses advanced techniques such as RIT-seq, phosphoproteomics, and CRISPR-based tools to dissect these mechanisms at the molecular level. The recent publications of Lucy Glover span molecular parasitology, DNA damage response, and diagnostic development. Key themes include the role of the MRN complex in DNA repair, phosphoproteomic profiling of DNA damage responses, and the design of CRISPR-based diagnostics for HAT. Her work reveals how chromosomal context influences repair pathways and antigenic variation, contributing to a deeper understanding of parasite biology. While no formal scientific awards are listed in the provided text, her contributions are evident through high-impact publications and leadership in collaborative research projects. Lucy Glover advises several PhD and postdoctoral researchers, including Emilia MacLaughlin, Nuria Sima Teruel, and Alix Thivolle. Her lab is supported by institutional initiatives such as LabEx IBEID and transversal drug discovery programs. She collaborates with teams working on host-pathogen interactions, genomics, and infectious disease epidemiology. Her laboratory is part of the Department of Parasites and Insect Vectors and participates in departmental retreats and seminars. The team includes post-docs, research engineers, and administrative staff, reflecting a collaborative and interdisciplinary research environment focused on combating neglected tropical diseases.

• Molecular Parasitology
• DNA Repair
• Antigenic Variation
• +7 more

Louis Lambrechts is a Researcher and Head of the Insect Infection & Immunity Group at the Institut Pasteur in Paris, France, within the Department of Virology. His research focuses on the ecology, evolution, and genetics of mosquito-virus interactions, particularly involving Aedes aegypti and arboviruses such as dengue and Zika. He leads a dynamic research team and multiple national and international projects funded by agencies including ANR and EU consortia. His research interests include arbovirus transmission dynamics, vectorial capacity, mosquito genetics, evolutionary ecology, host-pathogen interactions, and the role of microbiota in vector competence. He employs genomics, quantitative genetics, and experimental evolution to understand the mechanisms underlying variation in mosquito susceptibility to viral infection. His work has important implications for predicting and controlling arboviral disease outbreaks. Lambrecht’s recent publications reveal key insights into the genetic and environmental factors influencing arbovirus transmission, including the role of mosquito population variation in Zika transmission in Africa, the impact of endogenous viral elements, and the discovery of antiviral roles for cytochrome P450 enzymes. His research integrates molecular biology, field studies, and computational modelling, contributing to a comprehensive understanding of vector-borne disease systems. He has mentored numerous PhD students, postdoctoral researchers, and visiting scientists, fostering a collaborative and interdisciplinary research environment. His lab collaborates widely with institutions across Europe, Africa, and the Americas. Lambrecht’s work is supported by multiple ongoing projects such as CAZIKANO, INTRANZIGEANT, ANR PILGRIM, and LIPOARBO-IVI, focusing on Zika virus transmission, genetic drivers of vectorial capacity, and mosquito-virus specificity. His lab is also involved in broader initiatives like the LabEx IBEID and the Emerging Infectious Diseases program at Institut Pasteur.

• Arbovirus transmission
• Insect-virus interactions
• Mosquito genetics
• +12 more

Dr. Pascal Crépey is a Professor at the School of Advanced Studies in Public Health (EHESP) in Rennes, France. He specializes in epidemiology, biostatistics, and the dynamics of communicable diseases. Affiliated with the Department of Quantitative Methods in Public Health (METIS) and UMR 6051 ARENES, his work bridges mathematical modeling, health economics, and infectious disease surveillance. He coordinates the IDEA Field Epidemiology Course and leads research on pandemic mitigation strategies, antibiotic resistance networks, and vaccine effectiveness. Education: Doctorate in Biomathematics and Biostatistics from Pierre and Marie Curie University Dr. Crépey’s research focuses on infectious disease modeling , particularly influenza , COVID-19 , and RSV . His work examines non-pharmaceutical interventions, health economics of prevention , and regional healthcare network dynamics in spreading antibiotic-resistant bacteria. He has authored over 60 peer-reviewed articles. His recent publications highlight trends in Long COVID resource utilization , high-dose influenza vaccines , and mathematical modeling for pandemic preparedness . Key themes include cross-border healthcare coordination, vaccine hesitancy , and big data epidemiology . Dr. Crépey actively trains field epidemiologists through the IDEA course and contributes to policy discussions on influenza vaccination strategies and epidemiological surveillance .

• Epidemiology
• Vaccines
• Modeling
• +10 more

Maia Delage Toriel is a dermatologist and researcher at Institut Pasteur , focusing on Hidradenitis Suppurativa (HS) pathogenesis, microbiota interactions, and innovative therapeutic approaches. She leads key projects like SHINE-HS (hormonal influences), ABCESS2 (antibiotic regimens), and ROXANE (genetics and microbiota). Education: Medical studies at University of Necker (1997–2005) Dermatology residency at CHRU Tours (2005–2009) Diploma in Skin Cancerology (2008–2009) Head of Clinic Assistant in Dermatology at Bobigny (2009–2012) Research Interests center on HS etiology, including: Microbiota-host interface dysregulation Tryptophan catabolism and inflammation Sex-related dimorphism in disease manifestation Antibiotic resistance patterns Development of dynamic severity scoring systems (e.g., IHS4) Publications and clinical trials highlight her work on antimicrobial strategies, microbial profiling, and surgical outcomes. Her studies integrate metagenomics , metabolomics , and clinical data to address HS complexity. Collaborations span multidisciplinary teams at Institut Pasteur, focusing on translational immunology, microbiome dynamics, and open science initiatives.

• Dermatology
• Microbiology
• Inflammation
• +5 more

Nolwenn Dheilly is a researcher at the Pasteur Institute in Paris, France, contributing to studies on emerging infectious diseases, particularly in the areas of virology, parasitology, and microbiome science. She is actively involved in pathogen discovery and molecular characterization of viruses and parasites, with a focus on zoonotic agents and host-pathogen interactions. Her research interests span Virology , Parasitology , Microbiome , Emerging Infectious Diseases , Zoonoses , Metagenomics , Molecular Virology , and Host-Pathogen Interactions . Her work integrates molecular biology, genomics, and ecological perspectives to understand how microbial communities influence parasitic life cycles and disease transmission. The recent publications highlight a strong trend in viral discovery and classification, including work on Jingchuvirales, circoviruses, and flaviviruses like West Nile and tick-borne encephalitis virus. Her research also explores the virome of parasites and the role of symbiotic microbes in helminth evolution. These studies are critical for advancing diagnostics, understanding disease emergence, and informing public and veterinary health strategies. Scientific Awards: No awards listed in the provided text. Advising and Grants: No formal students or grants are mentioned in the available information. However, her collaborative work across multiple institutions and projects, including Labex IBEID and ANR PREZODE AMAZED, suggests active participation in funded research initiatives and interdisciplinary teams. Labs and Teams: She is part of a research group at the Pasteur Institute led by Marc Eloit, focusing on pathogen discovery and metagenomics. Her collaborations extend to teams working on veterinary virology, arboviruses, and parasitic microbiomes, indicating integration within a broad network of infectious disease research.

• Virology
• Parasitology
• Microbiome
• +5 more